Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 13/20 | 0.50 |
| ▸ | MC4R | P32245 | 5/20 | 0.48 |
| ▸ | CCKBR | P32239 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2628480 | 0.98 | KISS1R (0.54) | KISS1RCCKBR | |
| SCHEMBL17226116 | 0.89 | KISS1R (0.56) | KISS1RMC4RCCKBR | |
| SCHEMBL2628481 | 0.87 | NMUR2 (0.50) | KISS1R | |
| SCHEMBL2628476 | 0.82 | KISS1R (0.52) | KISS1R | |
| SCHEMBL2628477 | 0.81 | NMUR2 (0.58) | KISS1R | |
| SCHEMBL2628463 | 0.78 | NMUR2 (0.63) | — | |
| SCHEMBL2628482 | 0.78 | NMUR2 (0.56) | KISS1R | |
| SCHEMBL17226120 | 0.78 | NPY5R (0.58) | CCKBR | |
| SCHEMBL2625075 | 0.76 | NMUR2 (0.53) | KISS1R | |
| SCHEMBL17226128 | 0.76 | NMUR2 (0.66) | KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9175037-B2 | Neuromedin U derivative | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-11-03 | — | — | US | disclosed |
| US-20120094899-A1 | NEUROMEDIN U DERIVATIVE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094899-A1 | NEUROMEDIN U DERIVATIVE | NMUR1, NMUR2, NMBR | KISS1R 594/4885MC4R 178/4885CCKBR 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.